IndraLab

Statements



reach
"Salicylate and AICAR reduced NLRP3 and cleaved caspase-1 expression, and then decreased IL-1beta production."

reach
"AMPKalpha activator AICAR (5-aminoimidazole-4-carbox-amide-1-beta-d-ribofuranoside) inhibited NLRP3 inflammasome activation and decreased IL-1beta release and restored impaired insulin signal pathway induced by palmitate."

reach
"AICAR and salicylate inhibited NLRP3 induction and caspase-1 activation, and as a result, IL-1beta secretion was reduced."